TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
38 hedge funds and large institutions have $119M invested in Talis Biomedical Corporation Common Stock in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 11 closing their positions.
Holders
38
Holders Change
-5
Holders Change %
-11.63%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
16
Reduced
8
Closed
11
Calls
$2.14M
Puts
$342K
Net Calls
+$1.79M
Net Calls Change
+$1.79M
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$1.89M |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$409K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$520K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$1.49M |
| 5 |
PP
5
PDT Partners
New York
|
$188K |
